Ivermectine expliquée : faits, preuves et mythes courants

What ivermectin is designed to do

Ivermectin is an antiparasitic medicine. It works by targeting specific features of parasites’ nervous systems, leading to paralysis and death of the organism. This mechanism is highly effective for certain worms and external parasites because of the way their nerve channels function.

Viruses do not have nervous systems. Human cells also do not have the same biological targets as parasites. This basic difference is crucial. A medicine that works well for parasites cannot be assumed to work for viruses or cancer simply because it is active in one context.

How viral claims gained attention

Interest in ivermectin as a potential antiviral began with laboratory research. In controlled experiments using cells grown in dishes, ivermectin was shown to reduce viral replication under certain conditions. These findings were rapidly shared online, often presented as proof that ivermectin could treat viral illness in people.

What was frequently omitted was the scale of the doses involved. The concentrations used in laboratory experiments were far higher than those that can be safely achieved in the human body. To reach similar levels in people would require doses that carry a serious risk of harm.

Laboratory studies are a starting point for research, not evidence that a treatment works in real patients. Many substances show promise in early experiments and never become safe or effective medicines.

What clinical trials actually show

To determine whether a medicine truly works, it must be tested in well-designed clinical trials involving real people. These studies compare outcomes between those who receive the treatment and those who do not, allowing researchers to distinguish genuine effects from chance or natural recovery.

When ivermectin has been tested in this way for viral illnesses, including COVID-19, the results have been consistent. High-quality trials have not shown meaningful benefit. There has been no reliable evidence that ivermectin reduces infection rates, shortens recovery time, prevents hospital admission, or lowers the risk of death.

Some early studies that suggested benefit were later withdrawn or found to have serious flaws, including unreliable data, small sample sizes or poor study design. As larger and more rigorous trials were completed, the apparent benefits disappeared.

Why personal stories can be misleading

Many people remain convinced that ivermectin helped them recover from a viral illness. These experiences feel real and are often shared sincerely. However, most viral infections improve without specific treatment as the immune system clears the virus.

If someone takes a medicine during that natural recovery period, it is easy to assume the improvement was caused by the drug. Without proper comparison groups, there is no way to know whether the medicine made any difference at all.

This is why anecdotal experiences, no matter how compelling, cannot replace controlled clinical evidence.

Claims about cancer treatment

Claims that ivermectin can treat or cure cancer follow a similar pattern. Some laboratory studies have shown effects on cancer cells under artificial conditions, and these findings are often taken out of context online.

Cancer is not a single disease, and effective treatments must demonstrate clear benefits in people, such as improved survival or quality of life. Many substances affect cancer cells in laboratories but never translate into safe or effective treatments for patients.

At present, there is no reliable evidence that ivermectin is an effective cancer treatment in humans. Relying on it instead of proven cancer therapies risks delaying care that could genuinely improve outcomes.

The risks of misuse of ivermectin

When prescribed at appropriate doses for approved conditions, ivermectin is generally safe. Problems arise when it is taken inappropriately or for unproven uses. Higher doses increase the risk of side effects, particularly neurological symptoms.

The use of veterinary ivermectin (fenbendazole) is especially dangerous. Animal formulations are more concentrated and may contain ingredients that are not safe for human use. Hospital admissions linked to ivermectin misuse increased during the pandemic as misinformation spread.

Why misinformation spreads so easily

Health misinformation often spreads because it offers simple answers to complex and frightening problems. It can appeal to understandable frustration, fear and mistrust, particularly during periods of uncertainty. Scientific language, when removed from its proper context, can make weak evidence appear strong.

Once misinformation becomes embedded in online communities, correcting it can feel confrontational, even when the correction is based on solid evidence.

What the evidence tells us

Medical regulators and public health experts around the world have repeatedly reviewed the evidence on ivermectin. Their conclusions have remained consistent. Ivermectin should not be used to prevent or treat viral infections, including COVID-19, outside of properly conducted clinical trials. This position is not based on opinion or politics. It is based on the weight of available evidence.

Résumé

Ivermectin is a valuable medicine when used for the conditions it was designed to treat. It is not a cure-all. It does not treat viral infections, it does not cure cancer, and it does not prevent or treat COVID-19.

When faced with serious illness or worrying symptoms, the safest course is to rely on evidence-based treatments and professional medical advice rather than online claims. Clear, accurate information helps people make informed decisions about their health, and that clarity matters now more than ever.